Clinical Trials
Join groundbreaking research to advance early Parkinson's detection. Your participation helps millions worldwide.
Why Participate?
Make a difference while receiving world-class care
Help Others
Your participation directly contributes to developing better early detection methods that could help millions of people worldwide.
Expert Care
Receive comprehensive monitoring and care from leading neurologists and movement disorder specialists throughout the study.
Early Detection
Get access to cutting-edge screening technology that can detect Parkinson's up to 10 years before traditional diagnosis.
No Cost
All study-related tests, assessments, and monitoring are provided at no cost to participants. Travel compensation available.
Track Progress
Receive detailed reports on your vocal biomarkers and health metrics throughout the study period with quarterly updates.
Community
Join a supportive community of participants and researchers dedicated to advancing Parkinson's research and care.
Active Clinical Trials
Find the right study for you
EARLY-VOICE Study
NCT ID: NCT05847392 | Protocol: EV-2025-001
A comprehensive multi-center prospective study validating AI-powered voice-based screening for early Parkinson's disease detection in at-risk populations. This landmark study aims to establish voice analysis as a standard screening tool for prodromal Parkinson's disease.
2,000
Participants
3 Years
Follow-up
25
Locations
Jan 2025
Ongoing
Eligibility Criteria
Study Procedures
Baseline Assessment
Comprehensive neurological exam, voice recording, medical history review (2-3 hours)
Quarterly Voice Tests
30-second voice recordings every 3 months via smartphone app (5 minutes)
Annual Clinical Visits
Detailed neurological assessment, DaTscan imaging (if indicated), cognitive testing (4-5 hours)
Continuous Monitoring
AI analysis of voice patterns, early warning alerts, personalized reports
Principal Investigator
Dr. Sarah Chen, MD, PhD
Stanford University
Movement Disorders Specialist
Compensation
Study Sites
Stanford, CA
Boston, MA
New York, NY
Chicago, IL
Los Angeles, CA
+ 20 more locations
PRODROMAL-AI Trial
NCT ID: NCT05923847 | Protocol: PA-2024-003
Longitudinal study tracking vocal biomarker changes in individuals with REM sleep behavior disorder (RBD), a known prodromal marker of Parkinson's disease. This study aims to identify the earliest detectable voice changes that predict conversion to clinical Parkinson's.
500
of 500 target
5 Years
Follow-up
12
Sleep Centers
18%
Expected
Eligibility Criteria
Principal Investigator
Dr. Michael Rodriguez, MD
Johns Hopkins University
Sleep & Movement Disorders
Compensation
VOICE-PROGRESSION Study
NCT ID: NCT06012394 | Protocol: VP-2025-002
Monitoring vocal biomarker changes in newly diagnosed Parkinson's patients to understand disease progression patterns and validate voice analysis as a progression tracking tool. This study will establish baseline voice signatures for different disease stages.
300
Participants
2 Years
Follow-up
18
Clinics
Mar 2025
Recruiting
Eligibility Criteria
Principal Investigator
Dr. Emily Watson, PhD
Mayo Clinic
Neurology Research
Compensation
Check Your Eligibility
Quick assessment to find suitable trials
Participant Stories
Hear from those making a difference
Robert M.
Age 62 • 18 months
"Participating in this study gave me peace of mind. The early detection technology is incredible, and I feel like I'm contributing to something bigger than myself."
EARLY-VOICE Study
Linda S.
Age 58 • 2 years
"As someone with RBD, I was worried about my future. This study not only monitors my health but also gives me hope that we can catch Parkinson's early."
PRODROMAL-AI Trial
James K.
Age 71 • 14 months
"Being diagnosed with Parkinson's was scary, but this study helps me track my progression and gives my doctors valuable data to adjust my treatment."
VOICE-PROGRESSION
Frequently Asked Questions
Everything you need to know about participating
How much time will I need to commit?
Time commitment varies by study. Most trials require 2-4 hours for initial assessment, then quarterly 30-second voice recordings (5 minutes) and annual clinical visits (4-5 hours). Total time commitment is typically 10-15 hours per year.
Will I be compensated for my participation?
Yes! All participants receive compensation for their time and travel. Rates vary by study but typically range from $100-$200 per visit, plus travel reimbursement up to $100. Total compensation over the study period can reach $2,000-$4,000.
Is participation safe?
Absolutely. All studies are approved by institutional review boards (IRBs) and follow strict safety protocols. Voice recording is completely non-invasive. Any additional tests (like DaTscan) are only performed when medically indicated and with your consent.
Can I withdraw from a study?
Yes, participation is completely voluntary. You can withdraw at any time for any reason without penalty or loss of benefits. Your decision will not affect your regular medical care.
Will my insurance cover study-related costs?
All study-related procedures, tests, and assessments are provided at no cost to you. You will not be billed, and your insurance will not be charged for any study activities.
How will my data be protected?
We take data privacy seriously. All data is encrypted, de-identified, and stored securely in HIPAA-compliant systems. Your personal information is never shared without your explicit consent. You can request data deletion at any time.
What if I'm diagnosed with Parkinson's during the study?
If you're diagnosed during the study, you'll receive immediate referral to appropriate specialists and continue to receive study benefits. Your participation helps us understand disease progression and improve early detection methods.
Can I participate in multiple studies?
It depends on the specific studies. Some trials allow concurrent participation while others require exclusivity. Our study coordinators will help you determine which combinations are possible.
Safety & Ethics
Your safety and rights are our top priority
IRB Approved
All studies reviewed and approved by independent ethics committees
Informed Consent
Comprehensive consent process ensuring you understand all aspects
Participant Rights
Full protection of your rights, privacy, and wellbeing
FDA Compliant
Following all FDA guidelines for clinical research
Ready to Participate?
Join thousands of participants making a difference in Parkinson's research